Impact of Dose Escalation on the Efficacy of Salvage Radiotherapy for Recurrent Prostate Cancer-A Risk-Adjusted, Matched-Pair Analysis

Simple Summary This study evaluated 554 patients who underwent radical surgery for prostate cancer and later presented with persisting or rising PSA levels which required salvage radiotherapy. Our results showed that increasing the radiation dose during radiotherapy could reduce the risk of a second PSA relapse. These findings suggested that patients with failed prostatectomies might benefit from dose-escalated salvage radiotherapy to improve tumor control and postpone secondary treatments, such as hormonal or chemotherapy. Previous randomized trials have not provided conclusive evidence about dose escalations and associated toxicities for salvage radiotherapy (SRT) in prostate cancer. Here, we retrospectively analyzed whether dose escalations influenced progression-free survival in 554 patients that received salvage radiotherapy for relapses or persistently elevated prostate cancer antigen (PSA) after a radical prostatectomy. Patients received SRT between 1997 and 2017 at two University Hospitals in Germany. We compared patient groups that received radiation doses <7000 cGy (n = 225) or >= 7000 cGy (n = 329) to analyze the influence of radiation dose on progression-free survival. In a second matched-pair analysis of 216 pairs, we evaluated prognostic factors (pT2 vs. pT3-4, Gleason score [GS] <= 7 vs. GS >= 8, R0 vs. R1, and pre-SRT PSA <0.5 vs. >= 0.5 ng/mL). After a median follow-up of 6.8 (4.2-9.2) years, we found that escalated doses significantly improved progression-free survival (p = 0.0042). A multivariate analysis indicated that an escalated dose, lower tumor stages (pT2 vs. pT3/4), and lower GSs (<= 7 vs. 8-10) were associated with improved progression-free survival. There was no significant effect on overall survival. Our data suggested that escalating the radiation dose to >= 7000 cGy for SRT after a prostatectomy significantly improved progression-free survival. Longer follow-ups are needed for a comprehensive recommendation.

Automated summary

This study found that increasing the radiation dose during salvage radiotherapy could reduce the risk of prostate cancer relapse, suggesting that failed prostatectomy patients might benefit from dose-escalated salvage radiotherapy to improve tumor control and postpone secondary treatments. However, longer follow-ups are needed for a comprehensive recommendation.